Konstantin Konstantinov - Sep 16, 2022 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
Chief Technology Officer
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Konstantin Konstantinov
Stock symbol
CDAKQ
Transactions as of
Sep 16, 2022
Transactions value $
$0
Form type
4
Date filed
9/20/2022, 04:15 PM
Previous filing
Feb 21, 2023
Next filing
Jan 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Restricted Stock Units Award $0 +80K $0.00 80K Sep 16, 2022 Common Stock 80K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On September 16, 2022, the reporting person was granted 80,000 restricted stock units, vesting on June 30, 2023.